A new study published in the Journal of American Medical Association found that in patients with myocardial infarction (MI) ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with AMI.

Liberal blood transfusion after heart attack in patients with kidney disease (CKD) is not harmful, according to study results.